NFKB1 and neoplasm: Alterations in NFκB signaling can be the consequence of direct mutations of signaling molecules belonging to the NFκB signaling cascade, stimulation of signaling via the inflammatory tumor microenvironment or crosstalk between NFκB signaling and other dysregulated signaling pathways [5–8].